FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095622078> ?p ?o ?g. }

• W2095622078 endingPage "196" @default.
• W2095622078 startingPage "193" @default.
• W2095622078 abstract "Vox SanguinisVolume 87, Issue s2 p. 193-196 The top ten list of randomized controlled trials in transfusion medicine M. A. Blajchman, Corresponding Author M. A. Blajchman McMaster University, Departments of Pathology and Medicine and Canadian Blood Services, Hamilton, CanadaMorris A. Blajchman, McMaster University Medical Centre, 1200 Main Street West, HSC 2 N34, Hamilton, Ontario, Canada, L8N 3Z5 E-mail: [email protected]Search for more papers by this author M. A. Blajchman, Corresponding Author M. A. Blajchman McMaster University, Departments of Pathology and Medicine and Canadian Blood Services, Hamilton, CanadaMorris A. Blajchman, McMaster University Medical Centre, 1200 Main Street West, HSC 2 N34, Hamilton, Ontario, Canada, L8N 3Z5 E-mail: [email protected]Search for more papers by this author First published: 22 June 2004 https://doi.org/10.1111/j.1741-6892.2004.00489.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Evidence Based Medicine Working Group: Evidence Based Medicine. JAMA 1992; 268: 2420– 5 2 Rosenberg W, Donald D: Evidence based medicine: An approach to clinical problem solving. BMJ 1995; 310: 1122– 6 3 Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95: 2S– 4S 4 Green SB, Byar DP: Using observational data from registries to compare treatments. Stat Med 1984; 3: 361– 70 5 Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ: Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995; 108: 227S– 30S 6 Hill AB: The clinical trial. NEJM 1952; 247: 113– 9 7 Daniels M, Hill AB: Chemotherapy of pulmonary tuberculosis in young adults: An analysis of the combined results of three Medical Research Council trials. BMJ 1952; 1: 1162– 8 8 Alvarez JM, Jackson LR, Chatwin C, Smolich JJ: Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective, randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 2001; 122: 457– 63 9 Anderson NA, Gray S, Copplestone JA, Chan DC, Hamon M, Prentice AG, Johnson SA, Phillips M, Van Waeg G, Oakhill A, Abeyasekera S, Pamphilon DH: A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: Corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med 1997; 7: 33– 9 10 Bedirhan MA, Turna A, Yagan N, Tasci O: Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: Results of a randomized double-blind study. Eur J Cardiothorac Surg 2001; 20: 1122– 7 11 Billote DB, Glisson SN, Green D et al.: A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002; 8: 1299– 304 12 Blajchman MA, Bull SB, Feinman SV for the Canadian Post-transfusion Hepatitis Prevention Study Group: Post-transfusion hepatitis: A multicentre randomized trial to evaluate the impact of the non-A, non-B surrogate tests (ALT and anti-HBc). Lancet 1995; 345: 21– 5 13 Blundell EL, Pamphilon DH, Fraser ID, Menitove JE, Greenwalt TJ, Snyder EL, Repucci AJ, Hedberg SL, Anderson JK, Buchholz DH, Kagen LR, Aster RH: A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy. Transfusion 1996; 36: 296– 302 14 Codispoti M, Mankad PS: Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: Randomised controlled trial. Eur J Cardiothorac Surg 2002; 22: 200– 5 15 Collier AC, Kalish LA, Busch MP, Gernsheimer T, Assmann SF, Lane TA, Asmuth DM, Lederman MM, Murphy EL, Kumar P, Kelley M, Flanigan TP, McMahon DK, Sacks HS, Kennedy MS, Holland PV: Viral Activation Transfusion Study Group: Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: The viral activation transfusion study: A randomized controlled trial. JAMA 2001; 285: 1592– 601 16 Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T: EPO Critical Care Trials Group: Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288: 2827– 35 17 Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27: 2346– 50 18 Couban S, Carruthers J, Andreou P, Klama LN, Barr R, Kelton JG, Heddle NM: Platelet transfusions in children: Results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion 2002; 42: 753– 8 19 De Wildt-Eggen J, Nauta S, Schrijver JG, Van Marwijk Kooy M, Bins M, Van Prooijen HC: Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: A prospective, randomized study. Transfusion 2000; 40: 398– 403 20 Dzik WH, Anderson JK, O'Neill EM, Assmann SF, Kalish LA, Stowell CP: A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002; 42: 1114– 22 21 Eng J, Kay PH, Murday AJ, Shreiti I, Harrison DP, Norfolk DR, Barnes I, Hawkey PM, Inglis TJ: Postoperative autologous transfusion in cardiac surgery: A prospective, randomised study. Eur J Cardiothorac Surg 1990; 4: 595– 600 22 Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104: 882– 8 23 Freeman JW, Williamson LM, Llewelyn C, Fisher N, Allain JP, Bellamy M, Baglin TP, Klinc J, Ala FA, Smith N, Neuberger J, Wreghitt T: A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation. Vox Sang 1998; 74 (Suppl. 1): 225– 9 24 Gmur J, Von Felten A, Osterwalder B, Honegger H, Hormann A, Sauter C, Deubelbeiss K, Berchtold W, Metaxas M, Scali G, Frick PG: Delayed alloimmunization using random single donor platelet transfusions: A prospective study in thrombocytopenic patients with acute leukemia. Blood 1983; 62: 473– 9 25 Goodnough LT, Despotis GJ, Merkel K, Monk TG: A randomized trial comparing acute normovolemic hemodilution and preoperative autologous blood donation in total hip arthroplasty. Transfusion 2000; 40: 1054– 7 26 Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S: Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood 2001; 98: 1346– 51 27 Goodnough LT, Monk TG, Despotis GJ, Merkel K: A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 1999; 77: 11– 6 28 Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, Moss GS: The first randomized trial of human polymerized haemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187: 113– 20 29 Hardy JF, Belisle S, Couturier A, Robitaille D: Randomized, placebo-controlled, double-blind study of an ultra-low-dose aprotinin regimen in reoperative and/or complex cardiac operations. J Cardiol Surg 1997; 12: 15– 22 30 Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP: Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10 000/micorL versus 20,000/microL. J Clin Oncol 1997; 15: 1143– 9 31 Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, Constantini LA, Patterson B, Roberts RS, Thorpe KE, Levine MN: A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002; 42: 556– 66 32 Heddle NM, Brox WT, Klama LN, Dickson LL, Levine MN: A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion 1992; 32: 742– 6 33 Heddle NM, Klama L, Kelton JG, Meyer R, Walker I, Dickson L, Chambers S, Levine MN: The use of anti-D to improve post-transfusion platelet response: A randomized trial. Br J Haematol 1995; 89: 163– 8 34 Heddle NM, Klama L, Meyer R, Walker I, Boshkov L, Roberts R, Chambers S, Podlosky L, OHoski P, Levine M: A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999; 39: 231– 8 35 Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625– 8 36 Houbiers JG, Brand A, Van De Watering LM, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, De Vries JE, et al.: Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573– 8 37 Houbiers JG, Van De Velde CJ, Van De Watering LM, Hermans J, Schreuder S, Bijnen AB, Pahlplatz P, Schattenkerk ME, Wobbes T, De Vries JE, Klementschitsch P, Van De Maas AH, Brand A: Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: A prospective study. Transfusion 1997; 37: 126– 34 38 Klaesson S, Ringden O, Ljungman P, Lonnqvist B, Wennberg L: Reduced blood transfusions requirements after allogeneic bone marrow transplantation: Results of a randomised, double-blind study with high-dose erythropoietin. Bone Marrow Transplant 1994; 13: 397– 402 39 Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, Ackerman SJ, Bleecker GC, Mangan KF: Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial. Transfusion 1999; 39: 674– 81 40 Kluter H, Chapuis B, Cazenave J-P et al. Apheresis platelets treated with the INTERCEPT blood system for pathogen inactivation provide platelet count increments and hemostasis comparable to conventional platelets. Vox Sang 2002; 83(Suppl.): 110a 41 Koshy M, Burd L, Wallace D, Moawad A, Baron J: Prophylactic red-cell transfusions in pregnant patients with sickle cell disease: A randomized cooperative study. N Engl J Med 1988; 319: 1447– 52 42 Lee EJ, Schiffer CA: ABO compatibility can influence the results of platelet transfusion: Results of a randomized trial. Transfusion 1989; 29: 384– 9 43 Lemmer JH Jr, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, Holt WW, Karp RB, Laub GW, Lipton MJ, et al.: Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency: A multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 1994; 107: 543– 51 44 Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ: Polymerized bovine haemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124: 35– 42 45 McCullough J, Vesole D, Benjamin RJ et al. Pathogen inactivated platelets using Helinx™ technology are hemostatically effective in thrombocytopenic patients. The SPRINT Trial. Blood 2001; 98: 450a 46 Messerschmidt GL, Makuch R, Appelbaum F, Ungerleider RS, Abrams R, ODonnell J, Holohan TV, Fontana J, Wright D, Anagnou NP, et al.: A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients. Cancer 1988; 62: 795– 801 47 Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ: A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91: 24– 33 48 Nuttall GA, Santrach PJ, Oliver WC Jr, Ereth MH, Horlocker TT, Cabanela ME, Trousdale RT, Bryant S, Currie TW: A prospective randomized trial of the surgical blood order equation for ordering red cells for total hip arthroplasty patients. Transfusion 1998; 38: 828– 33 49 Oksanen K, Kekomaki R, Ruutu T, Koskimies S, Myllyla G: Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components: A randomized trial. Transfusion 1991; 31: 588– 94 50 Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI: Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: A randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med 1996; 101: 22S– 7S 51 Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI: The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. Transfusion 1996; 36: 29– 36 52 Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia: Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med 1997; 337: 1870– 5 53 Reed RL, Ciavarella D, Heimbach DM, Baron L, Pavlin E, Counts RB, Carrico CJ: Prophylactic platelet administration during massive transfusion: A prospective, randomized, double-blind clinical study. Ann Surg 1986; 203: 40– 8 54 Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325: 393– 7 55 Rock G, Shumak K, Kelton J, Blanchette VS, Buskard N, Nair R, Spasoff R: Thrombotic thrombocytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group. Transfusion 1992; 32: 710– 4 56 Sanfilippo FP, Bollinger RR, MacQueen JM, Brooks BJ, Koepke JA: A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion 1985; 25: 116– 9 57 Schiffer CA, Dutcher JP, Aisner J, Hogge D, Wiernik PH, Reilly JP: A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia. Blood 1983; 62: 815– 20 58 Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N, Thompson D, Sniderman S, Ballard R, Phibbs RH: Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 1991; 118: 949– 55 59 Shanwell A, Larsson S, Aschan J, Rigden O: A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients. Eur J Haematol 1992; 49: 77– 81 60 Sintnicolaas K, Van Marwijk Kooij M, Van Prooijen HC, Van Dijk BA, Van Putten WL, Claas FH, Novotny VM, Brand A: Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study. Blood 1995; 85: 824– 8 61 Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176: 462– 6 62 Tobe CE, Vocelka C, Sepulvada R, Gillis B, Nessly M, Verrier ED, Hofer BO: Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass: A prospective, randomized, blinded study. J Thorac Cardiovasc Surg 1993; 105: 1007– 13 63 TRAP Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861– 9 64 Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B: Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: A randomized crossover study. Lancet 2002; 359: 2145– 52 65 Van De Watering LM, Hermans J, Houbiers JG, Van Den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 1998; 97: 562– 8 66 Van De Watering L, Hermans J, Witvliet M, Versteegh M, Brand A: HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: A randomized controlled trial. Transfusion 2003; 43: 765– 71 67 Van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Kluter H, Vermeij H, Kappers-Klunne M, De Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L; euroSPRITE Trial: Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial. Blood 2003; 101: 2426– 33 68 Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ; Stroke Prevention Trail in Sickle Cell Anemia: Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion 2001; 41: 1086– 92 69 Wang SE, Lara PN Jr, Lee-Ow A, Reed J, Wang LR, Palmer P, Tuscano JM, Richman CM, Beckett L, Wun T: Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double-blind placebo-controlled trial. Am J Hematol 2002; 70: 191– 4 70 Wasser MN, Houbiers JG, D’Amaro J, Hermans J, Huysmans HA, Van Konijnenburg GC, Brand A: The effect of fresh versus stored blood on post-operative bleeding after coronary bypass surgery: A prospective randomized study. Br J Haematol 1989; 72: 81– 4 71 Williamson LM, Llewelyn CA, Fisher NC, Allain JP, Bellamy MC, Baglin TP, Freeman J, Klinck JR, Ala FA, Smith N, Neuberger J, Wreghitt TG: A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 1999; 39: 1227– 34 72 Williamson LM, Wimperis JZ, Williamson P, Copplestone JA, Gooi HC, Morgenstern GR, Norfolk DR: Bedside filtration of blood products in the prevention of HLA alloimmunization: A prospective randomized study. Alloimmunisation Study Group. Blood 1994; 83: 3028– 35 Citing Literature Volume87, Issues2July 2004Pages 193-196 ReferencesRelatedInformation" @default.
• W2095622078 created "2016-06-24" @default.
• W2095622078 creator A5014421997 @default.
• W2095622078 date "2004-07-01" @default.
• W2095622078 modified "2023-09-25" @default.
• W2095622078 title "The top ten list of randomized controlled trials in transfusion medicine" @default.
• W2095622078 cites W1557415260 @default.
• W2095622078 cites W1563175207 @default.
• W2095622078 cites W180044324 @default.
• W2095622078 cites W1890331917 @default.
• W2095622078 cites W1904761839 @default.
• W2095622078 cites W1935691618 @default.
• W2095622078 cites W1964367165 @default.
• W2095622078 cites W1968108949 @default.
• W2095622078 cites W1970827178 @default.
• W2095622078 cites W1973421185 @default.
• W2095622078 cites W1975270990 @default.
• W2095622078 cites W1978291922 @default.
• W2095622078 cites W1986094971 @default.
• W2095622078 cites W1997559766 @default.
• W2095622078 cites W1998508664 @default.
• W2095622078 cites W1999026703 @default.
• W2095622078 cites W2000400007 @default.
• W2095622078 cites W2003027963 @default.
• W2095622078 cites W2006817311 @default.
• W2095622078 cites W2007164263 @default.
• W2095622078 cites W2011045822 @default.
• W2095622078 cites W2012149199 @default.
• W2095622078 cites W2013007007 @default.
• W2095622078 cites W2014514659 @default.
• W2095622078 cites W2017883728 @default.
• W2095622078 cites W2018402959 @default.
• W2095622078 cites W2039846470 @default.
• W2095622078 cites W2044484850 @default.
• W2095622078 cites W2046064717 @default.
• W2095622078 cites W2048176236 @default.
• W2095622078 cites W2051021885 @default.
• W2095622078 cites W2067465736 @default.
• W2095622078 cites W2073236166 @default.
• W2095622078 cites W2075346991 @default.
• W2095622078 cites W2078736533 @default.
• W2095622078 cites W2087213683 @default.
• W2095622078 cites W2090061778 @default.
• W2095622078 cites W2090547773 @default.
• W2095622078 cites W2094548376 @default.
• W2095622078 cites W2097517425 @default.
• W2095622078 cites W2116711161 @default.
• W2095622078 cites W2117029299 @default.
• W2095622078 cites W2118384332 @default.
• W2095622078 cites W2118783071 @default.
• W2095622078 cites W2120993625 @default.
• W2095622078 cites W2121570694 @default.
• W2095622078 cites W2124086403 @default.
• W2095622078 cites W2128655828 @default.
• W2095622078 cites W2130020938 @default.
• W2095622078 cites W2130362897 @default.
• W2095622078 cites W2135246481 @default.
• W2095622078 cites W2136886036 @default.
• W2095622078 cites W2148621382 @default.
• W2095622078 cites W2148973954 @default.
• W2095622078 cites W2155029383 @default.
• W2095622078 cites W2155208959 @default.
• W2095622078 cites W2164729929 @default.
• W2095622078 cites W2165626995 @default.
• W2095622078 cites W2165898710 @default.
• W2095622078 cites W2171187245 @default.
• W2095622078 cites W2277073464 @default.
• W2095622078 cites W2312239978 @default.
• W2095622078 cites W2315173715 @default.
• W2095622078 cites W2334213116 @default.
• W2095622078 cites W2648190770 @default.
• W2095622078 cites W4245946220 @default.
• W2095622078 cites W4250903776 @default.
• W2095622078 cites W4254010053 @default.
• W2095622078 cites W4324114509 @default.
• W2095622078 cites W50257404 @default.
• W2095622078 doi "https://doi.org/10.1111/j.1741-6892.2004.00489.x" @default.
• W2095622078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15209915" @default.
• W2095622078 hasPublicationYear "2004" @default.
• W2095622078 type Work @default.
• W2095622078 sameAs 2095622078 @default.
• W2095622078 citedByCount "1" @default.
• W2095622078 crossrefType "journal-article" @default.
• W2095622078 hasAuthorship W2095622078A5014421997 @default.
• W2095622078 hasConcept C141071460 @default.
• W2095622078 hasConcept C168563851 @default.
• W2095622078 hasConcept C177713679 @default.
• W2095622078 hasConcept C2779473830 @default.
• W2095622078 hasConcept C2780014101 @default.
• W2095622078 hasConcept C55493867 @default.
• W2095622078 hasConcept C71924100 @default.
• W2095622078 hasConcept C79592252 @default.
• W2095622078 hasConcept C86803240 @default.
• W2095622078 hasConceptScore W2095622078C141071460 @default.
• W2095622078 hasConceptScore W2095622078C168563851 @default.
• W2095622078 hasConceptScore W2095622078C177713679 @default.
• W2095622078 hasConceptScore W2095622078C2779473830 @default.
• W2095622078 hasConceptScore W2095622078C2780014101 @default.

• next